Stock VRCA VERRICA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Verrica Pharmaceuticals Inc.

Equities

VRCA

US92511W1080

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
8.51 USD +2.16% Intraday chart for Verrica Pharmaceuticals Inc. -0.58% +16.26%
May. 15 Verrica Pharmaceuticals Amends Licensing Agreement With Torii Pharmaceutical for Phase 3 Trial of Ycanth MT
May. 15 Verrica Pharmaceuticals Inc. Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study Ycanth for the Treatment of Common Warts CI
3855ffe32d36ee2.zqSdcI4Y0gaoffIJZfT4vypLCjP-VqGznKLFsx49FXw.q5euB81Clk2RKIRhCbq7iHkNQnnJIPv2sZGi2GsPJCyenbAWz1akfs8akQ~f8e14b9cf66a86dba7f68486ebfa30f4
  1. Stock Market
  2. Equities
  3. VRCA Stock
  4. Charts Verrica Pharmaceuticals Inc.
  5. News Chart